Position in NVS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,483,041
+$36,957 QoQ
Shares Held
9,463
-0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#509
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cullen/Frost Bankers, Inc. holds $397,272,361 across 15 Drug Manufacturers - General names. NVS ranks #11 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
101,158 | $121,331,950 | |
| 2 | ABBV |
AbbVie Inc.
|
341,851 | $86,023,385 | |
| 3 | JNJ |
Johnson & Johnson
|
308,337 | $78,308,347 | |
| 4 | MRK |
Merck & Co., Inc.
|
309,626 | $39,786,941 | |
| 5 | AMGN |
Amgen Inc
|
69,521 | $25,174,944 | |
| 6 | NVO |
Novo Nordisk A S
|
341,905 | $16,390,925 | |
| 7 | AZN |
Astrazeneca PLC
|
84,701 | $16,061,003 | |
| 8 | PFE |
Pfizer Inc
|
209,637 | $5,048,058 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,483,041 | 9,463 | Shares | Defined | 2026-07-27 | |
| 2026-03-31 | $1,446,084 | 9,467 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,312,798 | 9,522 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $1,233,412 | 9,618 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $1,269,878 | 10,494 | Shares | Defined | 2025-07-30 | |
| 2025-03-31 | $1,077,677 | 9,667 | Shares | Defined | 2025-05-02 | |
| 2024-12-31 | $934,565 | 9,604 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $1,193,217 | 10,374 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $1,141,357 | 10,721 | Shares | Defined | 2024-08-05 | |
| 2024-03-31 | $1,179,622 | 12,195 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,220,525 | 12,088 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $2,328,214 | 22,857 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $2,267,548 | 22,471 | Shares | Defined | 2023-08-04 | |
| 2023-03-31 | $2,140,288 | 23,264 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $2,324,790 | 25,626 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,273,535 | 29,911 | Shares | Defined | 2022-11-07 | |
| 2022-06-30 | $2,509,780 | 29,691 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $2,633,816 | 30,015 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $2,743,933 | 31,370 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $2,635,687 | 32,229 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $3,088,291 | 33,848 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $2,893,754 | 33,853 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $3,732,251 | 39,524 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $3,544,228 | 40,757 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $3,273,503 | 37,480 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $3,009,754 | 36,504 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||